Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Archives of Dermatological Research
Published in: Archives of Dermatological Research 4/2018

01-05-2018 | Original Paper

Reevaluation of established and new criteria in differential diagnosis of Spitz nevus and melanoma

Authors: A. Ritter, M. Tronnier, B. Vaske, C. Mitteldorf

Published in: Archives of Dermatological Research | Issue 4/2018

Login to get access

Abstract

The histopathologic differentiation between Spitz nevus and melanoma is of particular interest in routine diagnostic procedures of melanocytic tumors. Atypical Spitz nevi are sometimes difficult to distinguish from melanoma. There is still no single criterion that ensures a distinction of melanoma and atypical Spitz nevus. The aim of this study was to reevaluate established and new criteria to differentiate Spitz nevus from melanoma more reliably. We analyzed 25 melanomas with a Breslow index ≥ 1 mm and 18 classical compound Spitz nevi concerning their histopathologic, immunohistochemical and molecular genetic characteristics. Moreover, clinical follow-up data for 5 years were collected. We found statistically significant differences between Spitz nevus and melanoma for the following features: pagetoid spread, atypia, maturation, elastosis, Kamino bodies, p16 expression, and the staining pattern of HMB45. BRAF was positive in 7/21 melanomas and in 1/14 Spitz nevi. Fluorescence in situ hybridization confirmed the histopathologic diagnosis in 36/37 cases. The established clinical, histopathologic, and immunohistochemical criteria to differentiate Spitz nevus and melanoma could be reproduced in our collective. Especially, the expression of p16, BRAF analysis and fluorescence in situ hybridization proved to be helpful tools to improve the differentiation of Spitz nevus and melanoma in our study. Nevertheless, there is—until now—no reliable histopathologic and immunohistochemical parameter which can discriminate Spitz nevus and melanoma with absolute certainty.
Literature
1.
Al Dhaybi R, Agoumi M, Gagne I, McCuaig C, Powell J, Kokta V (2011) p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi. J Am Acad Dermatol 65(2):357 – 63CrossRefPubMed
2.
Alonso SR, Ortiz P, Pollan M, Perez-Gomez B, Sanchez L, Acuna MJ, Pajares R, Martinez-Tello FJ, Hortelano CM, Piris MA, Rodriguez-Peralto JL (2004) Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study. Am J Pathol 164(1):193–203CrossRefPubMedCentralPubMed
3.
Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, Eggermont AM, Flaherty KT, Gimotty PA, Kirkwood JM, McMasters KM, Mihm MC Jr, Morton DL, Ross MI, Sober AJ, Sondak VK (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27(36):6199 – 206CrossRefPubMedCentralPubMed
4.
Barnhill RL, Argenyi ZB, From L, Glass LF, Maize JC, Mihm MC Jr, Rabkin MS, Ronan SG, White WL, Piepkorn M (1999) Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol 30(5):513 – 20CrossRefPubMed
5.
Barnhill RL, Flotte TJ, Fleischli M, Perez-Atayde A (1995) Cutaneous melanoma and atypical Spitz tumors in childhood. Cancer 76(10):1833–1845CrossRefPubMed
6.
Berlingeri-Ramos AC, Morales-Burgos A, Sanchez JL, Nogales EM (2010) Spitz nevus in a Hispanic population: a clinicopathological study of 130 cases. Am J Dermatopathol 32(3):267 – 75PubMed
7.
Blokx WA, van Dijk MC, Ruiter DJ (2010) Molecular cytogenetics of cutaneous melanocytic lesions - diagnostic, prognostic and therapeutic aspects. Histopathology 56(1):121 – 32CrossRefPubMed
8.
Cerroni L, Barnhill R, Elder D, Gottlieb G, Heenan P, Kutzner H, LeBoit PE, Mihm M Jr, Rosai J, Kerl H (2010) Melanocytic tumors of uncertain malignant potential: Results of a tutorial held at the XXIX Symposium of the International Society of Dermatopathology in Graz, October 2008. Am J Surg Pathol 34(3):314 – 26CrossRefPubMed
9.
Cesinaro AM, Foroni M, Sighinolfi P, Migaldi M, Trentini GP (2005) Spitz nevus is relatively frequent in adults: a clinico-pathologic study of 247 cases related to patient’s age. Am J Dermatopathol 27(6):469 – 75CrossRefPubMed
10.
Crotty KA, McCarthy SW, Palmer AA, Ng AB, Thompson JF, Gianoutsos MP, Shaw HM (1992) Malignant melanoma in childhood: a clinicopathologic study of 13 cases and comparison with Spitz nevi. World J Surg 16(2):179 – 85CrossRefPubMed
11.
Crotty KA, Scolyer RA, Li L, Palmer AA, Wang L, McCarthy SW (2002) Spitz naevus versus Spitzoid melanoma: when and how can they be distinguished? Pathology 34(1):6–12CrossRefPubMed
12.
Da Forno PD, Pringle JH, Fletcher A, Bamford M, Su L, Potter L, Saldanha G (2009) BRAF, NRAS and HRAS mutations in spitzoid tumours and their possible pathogenetic significance. Br J Dermatol 161(2):364 – 72CrossRefPubMed
13.
DeMarchis EH, Swetter SM, Jennings CD, Kim J (2014) Fluorescence in situ hybridization analysis of atypical melanocytic proliferations and melanoma in young patients. Pediatr Dermatol 31(5):561–569CrossRefPubMedCentralPubMed
14.
Emley A, Yang S, Wajapeyee N, Green MR, Mahalingam M (2010) Oncogenic BRAF and the tumor suppressor IGFBP7 in the genesis of atypical spitzoid nevomelanocytic proliferations. J Cutan Pathol 37(3):344–349CrossRefPubMed
15.
Ferrara G, Argenziano G, Soyer HP, Chimenti S, Di Blasi A, Pellacani G, Peris K, Piccolo D, Rubegni P, Seidenari S, Staibano S, Zalaudek I, De Rosa G (2005) The spectrum of Spitz nevi: a clinicopathologic study of 83 cases. Arch Dermatol 141(11):1381–1387CrossRefPubMed
16.
Ferrara G, De Vanna AC (2016) Fluorescence In Situ Hybridization for Melanoma Diagnosis: A Review and a Reappraisal. Am J Dermatopathol 38(4):253 – 69CrossRefPubMed
17.
Fullen DR, Poynter JN, Lowe L, Su LD, Elder JT, Nair RP, Johnson TM, Gruber SB (2006) BRAF and NRAS mutations in spitzoid melanocytic lesions. Mod Pathol 19(10):1324–1332CrossRefPubMed
18.
Gaiser T, Kutzner H, Palmedo G, Siegelin MD, Wiesner T, Bruckner T, Hartschuh W, Enk AH, Becker MR (2010) Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up. Mod Pathol 23(3):413–419CrossRefPubMed
19.
Garrido-Ruiz MC, Requena L, Ortiz P, Perez-Gomez B, Alonso SR, Peralto JL (2010) The immunohistochemical profile of Spitz nevi and conventional (non-Spitzoid) melanomas: a baseline study. Mod Pathol 23(9):1215–1224CrossRefPubMed
20.
Gartmann H, Ganser M (1985) The Spitz nevus. Spindle cell and/or epithelioid cell nevus–a histological analysis of 652 tumors. Z Hautkr 60(1–2):29–30, 34 – 6, 39–42PubMed
21.
George E, Polissar NL, Wick M (2010) Immunohistochemical evaluation of p16INK4A, E-cadherin, and cyclin D1 expression in melanoma and Spitz tumors. Am J Clin Pathol 133(3):370–379CrossRefPubMed
22.
Gerami P, Jewell SS, Morrison LE, Blondin B, Schulz J, Ruffalo T, Matushek, Legator M, Jacobson K, Dalton SR, Charzan S, Kolaitis NA, Guitart J, Lertsbarapa T, Boone S, LeBoit PE, Bastian BC (2009) P,4th. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma. Am J Surg Pathol 33(8):1146–1156CrossRefPubMed
23.
Gill M, Renwick N, Silvers DN, Celebi JT (2004) Lack of BRAF mutations in Spitz nevi. J Invest Dermatol 122(5):1325–1326CrossRefPubMed
24.
Glatz K, Hartmann C, Antic M, Kutzner H (2010) Frequent mitotic activity in banal melanocytic nevi uncovered by immunohistochemical analysis. Am J Dermatopathol 32(7):643–649CrossRefPubMed
25.
Greaves WO, Verma S, Patel KP, Davies MA, Barkoh BA, Galbincea JM, Yao H, Lazar AJ, Aldape KD, Medeiros LJ, Luthra R (2013) Frequency and spectrum of BRAF mutations in a retrospective, single-institution study of 1112 cases of melanoma. J Mol Diagn 15(2):220–226CrossRefPubMedCentralPubMed
26.
Harms KL, Lowe L, Fullen DR, Harms PW (2015) Atypical Spitz Tumors: A Diagnostic Challenge. Arch Pathol Lab Med 139(10):1263–1270CrossRefPubMed
27.
Haupt HM, Stern JB (1995) Pagetoid melanocytosis. Histologic features in benign and malignant lesions. Am J Surg Pathol 19(7):792–797CrossRefPubMed
28.
Hilliard NJ, Krahl D, Sellheyer K (2009) p16 expression differentiates between desmoplastic Spitz nevus and desmoplastic melanoma. J Cutan Pathol 36(7):753–759CrossRefPubMed
29.
Indsto JO, Kumar S, Wang L, Crotty KA, Arbuckle SM, Mann GJ (2007) Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions. J Cutan Pathol 34(6):448 – 55CrossRefPubMed
30.
Isaac AK, Lertsburapa T, Pathria Mundi J, Martini M, Guitart J, Gerami P (2010) Polyploidy in spitz nevi: A not uncommon karyotypic abnormality identifiable by fluorescence in situ hybridization. Am J Dermatopathol 32(2):144–148CrossRefPubMed
31.
Kamino H, Misheloff E, Ackerman AB, Flotte TJ, Greco MA (1979) Eosinophilic globules in Spitz’s nevi: New findings and a diagnostic sign. Am J Dermatopathol 1(4):323–324CrossRefPubMed
32.
Keller-Melchior R, Schmidt R, Piepkorn M (1998) Expression of the tumor suppressor gene product p16INK4 in benign and malignant melanocytic lesions. J Invest Dermatol 110(6):932–938CrossRefPubMed
33.
Kumar R, Angelini S, Czene K, Sauroja I, Hahka-Kemppinen M, Pyrhonen S, Hemminki K (2003) BRAF mutations in metastatic melanoma: a possible association with clinical outcome. Clin Cancer Res 9(9):3362–3368PubMed
34.
Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A (2015) TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep 5:11200CrossRefPubMedCentralPubMed
35.
36.
Maldonado JL, Fridlyand J, Patel H, Jain AN, Busam K, Kageshita T, Ono T, Albertson DG, Pinkel D, Bastian BC (2003) Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 95(24):1878–1890CrossRefPubMed
37.
Martin V, Banfi S, Bordoni A, Leoni-Parvex S, Mazzucchelli L (2012) Presence of cytogenetic abnormalities in Spitz naevi: a diagnostic challenge for fluorescence in-situ hybridization analysis. Histopathology 60(2):336 – 46CrossRefPubMed
38.
Mason A, Wititsuwannakul J, Klump VR, Lott J, Lazova R (2012) Expression of p16 alone does not differentiate between spitz nevi and spitzoid melanoma. J Cutan Pathol 39(12):1062–1074CrossRefPubMed
39.
McCarthy SW, Scolyer RA (2004) Melanocytic lesions of the face: diagnostic pitfalls. Ann Acad Med Singapore 33(4 Suppl):3 – 1
40.
McCarty KS Jr, Szabo E, Flowers JL, Cox EB, Leight GS, Miller L, Konrath J, Soper JT, Budwit DA, Creasman WT (1986) Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res 46(8 Suppl):4244s-4248 s
41.
42.
Mihic-Probst D, Mnich CD, Oberholzer PA, Seifert B, Sasse B, Moch H, Dummer R (2006) P16 Expression in Primary Malignant Melanoma is Associated with Prognosis and Lymph Node Status. Int J Cancer 118(9):2262–2268CrossRefPubMed
43.
Mihic-Probst D, Perren A, Schmid S, Saremaslani P, Komminoth P, Heitz PU (2004) Absence of BRAF gene mutations differentiates spitz nevi from malignant melanoma. Anticancer Res 24(4):2415–2418PubMed
44.
Miteva M, Lazova R (2010) Spitz nevus and atypical spitzoid neoplasm. Semin Cutan Med Surg 29(3):165 – 73CrossRefPubMed
45.
Morey AL, Murali R, McCarthy SW, Mann GJ, Scolyer RA (2009) Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation. Pathology 41(4):383–387CrossRefPubMed
46.
Nagore E, Oliver V, Botella-Estrada R, Moreno-Picot S, Guillen C, Fortea JM (2006) Clinicopathological analysis of 1571 cutaneous malignant melanomas in Valencia, Spain: factors related to tumour thickness. Acta Derm Venereol 86(1):50 – 6PubMed
47.
North JP, Garrido MC, Kolaitis NA, LeBoit PE, McCalmont TH, Bastian BC (2014) Fluorescence in situ hybridization as an ancillary tool in the diagnosis of ambiguous melanocytic neoplasms: A review of 804 cases. Am J Surg Pathol 38(6):824 – 31CrossRefPubMed
48.
Ottmann K, Tronnier M, Mitteldorf C (2015) Detection of mitotic figures in thin melanomas–immunohistochemistry does not replace the careful search for mitotic figures in hematoxylin-eosin stain. J Am Acad Dermatol 73(4):637 – 44CrossRefPubMed
49.
Palmedo G, Hantschke M, Rütten A, Mentzel T, Hugel H, Flaig MJ, Yazdi AS, Sander CA, Kutzner H (2004) The T1796A mutation of the BRAF gene is absent in Spitz nevi. J Cutan Pathol 31(3):266 – 70CrossRefPubMed
50.
Paradela S, Fonseca E, Pita S, Kantrow SM, Goncharuk VN, Diwan H, Prieto VG (2009) Spitzoid melanoma in children: clinicopathological study and application of immunohistochemistry as an adjunct diagnostic tool. J Cutan Pathol 36(7):740 – 52CrossRefPubMed
51.
Peters MS, Goellner JR (1986) Spitz naevi and malignant melanomas of childhood and adolescence. Histopathology 10(12):1289 – 302CrossRefPubMed
52.
Piris A, Mihm MC Jr, Hoang MP (2015) BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations. Hum Pathol 46(2):239 – 45CrossRefPubMed
53.
Pluot M, Joundi A, Grosshans E (1990) Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma. Ann Dermatol Venereol 117(10):691–699PubMed
54.
Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, Moses TY, Hostetter G, Wagner U, Kakareka J, Salem G, Pohida T, Heenan P, Duray P, Kallioniemi O, Hayward NK, Trent JM, Meltzer PS (2003) High frequency of BRAF mutations in nevi. Nat Genet 33(1):19–20CrossRefPubMed
55.
Requena C, Requena L, Kutzner H, Sanchez Yus E (2009) Spitz nevus: a clinicopathological study of 349 cases. Am J Dermatopathol 31(2):107 – 16CrossRefPubMed
56.
Requena C, Rubio L, Traves V, Sanmartin O, Nagore E, Llombart B, Serra C, Fernandez-Serra A, Botella R, Guillen C (2012) Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and spitzoid melanoma. Histopathology 61(5):899–909CrossRefPubMed
57.
Saldanha G, Purnell D, Fletcher A, Potter L, Gillies A, Pringle JH (2004) High BRAF mutation frequency does not characterize all melanocytic tumor types. Int J Cancer 111(5):705 – 10CrossRefPubMed
58.
Senetta R, Paglierani M, Massi D (2012) Fluorescence in-situ hybridization analysis for melanoma diagnosis. Histopathology 60(5):706 – 14CrossRefPubMed
59.
Shinozaki M, Fujimoto A, Morton DL, Hoon DS (2004) Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas. Clin Cancer Res 10(5):1753–1757CrossRefPubMed
60.
Skelton HG 3rd, Smith KJ, Barrett TL, Lupton GP, Graham JH (1991) HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation. Am J Dermatopathol 13(6):543 – 50CrossRefPubMed
61.
Sparrow LE, Eldon MJ, English DR, Heenan PJ (1998) p16 and p21WAF1 protein expression in melanocytic tumors by immunohistochemistry. Am J Dermatopathol 20(3):255 – 61CrossRefPubMed
62.
Spatz A, Calonje E, Handfield-Jones S, Barnhill RL (1999) Spitz tumors in children: A grading system for risk stratification. Arch Dermatol 135(3):282–285CrossRefPubMed
63.
Spatz A, Ruiter D, Hardmeier T, Renard N, Wechsler J, Bailly C, Avril MF, Kwee H, Bastian BC, Hill C, De Potter C, Prade M (1996) Melanoma in childhood: an EORTC-MCG multicenter study on the clinico-pathological aspects. Int J Cancer 68(3):317 – 24CrossRefPubMed
64.
Takata M, Lin J, Takayanagi S, Suzuki T, Ansai S, Kimura T, Cerroni L, Saida T (2007) Genetic and epigenetic alterations in the differential diagnosis of malignant melanoma and spitzoid lesion. Br J Dermatol 156(6):1287–1294CrossRefPubMed
65.
66.
Uguen A, Talagas M, Costa S, Duigou S, Bouvier S, De Braekeleer M, Marcorelles P (2015) A p16-ki-67-HMB45 immunohistochemistry scoring system as an ancillary diagnostic tool in the diagnosis of melanoma. Diagn Pathol 10:195CrossRefPubMedCentralPubMed
67.
van Dijk MC, Bernsen MR, Ruiter DJ (2005) Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma. Am J Surg Pathol 29(9):1145–1151CrossRefPubMed
68.
69.
Walsh N, Crotty K, Palmer A, McCarthy S (1998) Spitz nevus versus spitzoid malignant melanoma: an evaluation of the current distinguishing histopathologic criteria. Hum Pathol 29(10):1105–1112CrossRefPubMed
70.
Weedon D, Little JH (1977) Spindle and epithelioid cell nevi in children and adults. A review of 211 cases of the Spitz nevus. Cancer 40(1):217 – 25CrossRefPubMed
71.
Wiesner T, He J, Yelensky R, Esteve-Puig R, Botton T, Yeh I, Lipson D, Otto G, Brennan K, Murali R, Garrido M, Miller VA, Ross JS, Berger MF, Sparatta A, Palmedo G, Cerroni L, Busam KJ, Kutzner H, Cronin MT, Stephens PJ, Bastian BC (2014) Kinase fusions are frequent in Spitz tumours and spitzoid melanomas. Nat Commun 5:3116PubMedCentralPubMed
72.
Wiesner T, Kutzner H (2015) Morphological and genetic aspects of Spitz tumors. Pathologe 36(1):37–43, 45CrossRefPubMed
73.
Wiesner T, Kutzner H, Cerroni L, Mihm MC Jr, Busam KJ, Murali R (2016) Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy. Pathology 48(2):113 – 31CrossRefPubMedCentralPubMed
74.
Wiesner T, Murali R, Fried I, Cerroni L, Busam K, Kutzner H, Bastian BC (2012) A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. Am J Surg Pathol 36(6):818 – 30CrossRefPubMedCentralPubMed
75.
Yazdi AS, Palmedo G, Flaig MJ, Puchta U, Reckwerth A, Rutten A, Mentzel T, Hugel H, Hantschke M, Schmid-Wendtner MH, Kutzner H, Sander CA. Mutations of the BRAF gene in benign and malignant melanocytic lesions (2003). J Invest Dermatol 121(5):1160–1162
76.
Yeh I, Mully TW, Wiesner T, Vemula SS, Mirza SA, Sparatta AJ, McCalmont TH, Bastian BC, LeBoit PE (2014) Ambiguous melanocytic tumors with loss of 3p21. Am J Surg Pathol 38(8):1088–1095CrossRefPubMedCentralPubMed
Metadata
Title
Reevaluation of established and new criteria in differential diagnosis of Spitz nevus and melanoma
Authors
A. Ritter
M. Tronnier
B. Vaske
C. Mitteldorf
Publication date
01-05-2018
Publisher
Springer Berlin Heidelberg
Published in
Archives of Dermatological Research / Issue 4/2018
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-018-1818-8

Other articles of this Issue 4/2018

Archives of Dermatological Research 4/2018 Go to the issue

Original Paper

Treatment preferences and treatment satisfaction among psoriasis patients: a systematic review

Original Paper

Autologous platelet-rich plasma and triamcinolone acetonide intralesional injection in the treatment of oral erosions of pemphigus vulgaris: a pilot study

Original Paper

Effect of Dickkopf1 on the senescence of melanocytes: in vitro study

Original Paper

Effects of topical topiramate in wound healing in mice

Original Paper

Leptin regulates the pro-inflammatory response in human epidermal keratinocytes

Original Paper

Association between LCE gene polymorphisms and psoriasis vulgaris among Mongolians from Inner Mongolia